Premium
Rituximab: first monoclonal antibody for severe, active RA
Publication year - 2007
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.92
Subject(s) - medicine , rituximab , rheumatoid arthritis , monoclonal antibody , immunology , monoclonal , antibody , clinical efficacy , adverse effect
Rituximab (MabThera) is a monoclonal antibody that exerts a novel anti‐inflammatory action in rheumatoid arthritis via B‐cell depletion. In our New products review Michael Guida presents the clinical data relating to its efficacy and adverse effects, and Dr Michael Plant comments on its place in therapy. Copyright © 2007 Wiley Interface Ltd